NUREMBERG, Germany, Jan. 31, 2026 /PRNewswire/ — Tuya Smart (NYSE: TUYA, HKEX: 2391), a global AI cloud platform service provider, showcased a series of groundbreaking AI products at Spielwarenmesse 2026 in Nuremberg from January 27 to 31. At the event, Tuya also unveiled the secret behind the next generation of AI toys that are set […]
Category Archives: Pr Newswire
Announces Filing of Annual Report on Form 20-F for Fiscal Year 2025 BEIJING, Jan. 31, 2026 /PRNewswire/ — Origin Agritech Ltd. (NASDAQ: SEED) (the “Company” or “Origin”), a leading Chinese agricultural technology company, today announced financial results for the year ended September 30, 2025. Business Accomplishments and Highlights for the Year Ended September 30, 2025: […]
NEW YORK, Jan. 31, 2026 /PRNewswire/ — White Pearl Acquisition Corp. (the “Company”), a blank check company incorporated as a British Virgin Islands business company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses, today announced the pricing of its […]
ARMONK, N.Y., Jan. 31, 2026 /PRNewswire/ — The IBM (NYSE: IBM) board of directors has elected Ramon L. Laguarta to the board, effective March 1, 2026. IBM Corporation logo. Ramon L. Laguarta, 62, is the chairman and chief executive officer of PepsiCo. With a strong commitment to performance and leadership, Mr. Laguarta has led PepsiCo, […]
NEW YORK, Jan. 31, 2026 /PRNewswire/ — Planet Green Holdings Corp. (“Planet Green”, the “Company”) (NYSE American: PLAG) announced today that the Company had become aware of unusual trading activity in its common stock on the New York Stock Exchange American (the “NYSE”) on January 30, 2026. The Company is issuing this press release pursuant to […]
Pr Newswire
Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit
30
Jan
Jan
TONMYA demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT study Unique sublingual formulation designed for bedtime dosing bypasses first-pass metabolism, optimizing parent-drug exposure during sleep and decreasing levels of the persistent active metabolite Treatment was well tolerated with minimal effects on weight or blood pressure CHATHAM, N.J., Jan. 30, […]
30
Jan
Jan
Immunocore announces R&D leadership evolution Dr. David Berman will depart the Company Dr. Mohammed Dar, Chief Medical Officer, and Mark Moyer, Head of Regulatory Sciences, promoted to Executive Vice President roles (OXFORDSHIRE, England & RADNOR, Penn. & GAITHERSBURG, Md., US, 30 January 2026) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology […]
Pr Newswire
Press Release: Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease
30
Jan
Jan
Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease Recommendation supported by safety and efficacy results from several clinical studies and real-world evidence If approved, Rezurock would offer a new treatment option in the EU for adult patients and in children aged 12 years and older in late line chronic GVHD […]
30
Jan
Jan
Fourth quarter 2025 revenues increased 3% to $3.9 billion versus fourth quarter 2024; full year 2025 revenues increased 1% to $14.3 billion versus 2024 Fourth quarter 2025 Dupixent® global net sales (recorded by Sanofi) increased 34% to $4.9 billion versus fourth quarter 2024; full year 2025 Dupixent global net sales increased 26% to $17.8 billion […]
30
Jan
Jan
New YORK City, NY, Jan. 30, 2026 (GLOBE NEWSWIRE) — Visit PhenQ Official Website Here TL;DR Summary: Most people are reluctant to discuss weight reduction because it is such a delicate subject. The majority of people commit to eating better and exercising more. One of the key reasons why most individuals struggle to lose weight […]